London, June 12, 2026, 14:10 BST
- ICG shares rose about 2% on Friday after a sharp ex-dividend move the previous session.
- A Reuters report on Exail’s valuation dispute with creditor ICG added a fresh stock-specific item for investors to assess.
- The next major scheduled catalyst is ICG’s Q1 trading statement and AGM on July 15.
ICG plc shares rebounded on Friday, helped by a stronger London market and a stock-specific focus on a fresh credit dispute involving French technology group Exail. Hargreaves Lansdown’s delayed quote showed ICG at a 1,749p sell price and 1,750p buy price, up 34p, or 1.98%, while the FTSE 100 was up 0.88%; ICG’s own investor page showed the stock at 1,754p, up 2.21%, at 13:29 BST.
The move followed a 4.67% fall to 1,716p on Thursday, according to ICG’s share-price tool, a session that coincided with the stock going ex-dividend. Ex-dividend means new buyers no longer qualify for the upcoming dividend, so shares often adjust around that date; AJ Bell lists ICG’s latest dividend amount at 59.30p, with an ex-dividend date of June 11, a record date of June 12 and payment due on July 31.
The fresh item investors had to digest was Reuters’ report that Exail shares plunged after the company disclosed a €380 million gap in valuation views with creditor ICG over bonds and preference shares tied to a 2022 financing deal. Reuters reported that ICG argues the valuation should be based on Exail’s share price, while Exail supports a broader valuation method; TP ICAP Midcap Partners analyst Julien Thomas told Reuters, “Exail might be a victim of its own success,” and said he expected a friendly settlement with a potential cash premium of €210 million to €477 million. Reuters
For ICG shareholders, the Exail dispute matters because it touches the value of a structured-capital position rather than just a routine portfolio update. A favourable settlement could support realisations, meaning cash returned from an investment, but the bear case is that any prolonged disagreement adds timing risk and underlines how private-market and credit investments can depend on negotiated outcomes rather than simple market prices. Reuters also reported that Exail said its operations remain fully funded and that refinancing remains a priority, with completion targeted by the end of 2026.
The broader investment case still rests on ICG’s fee engine. In May, the company reported FY26 assets under management, or AUM, of $126 billion; fee-earning AUM of $87 billion, up 11% year-on-year; management fees of £685 million, up 13%; and fee-related earnings, or profit from recurring management fees before more volatile performance fees, of £350 million, up 23%. Chief Executive and CIO Benoît Durteste said, “FY26 was a strong year for ICG,” adding that the group was seeing “clear demand from institutional allocators globally.” ICG
Analyst sentiment remains constructive but not without caution. Berenberg lowered its ICG target price from 2,800p to 2,670p on June 4 while keeping a buy rating, with Sharecast reporting the broker’s view that the stock had been hit by wider sector read-across rather than purely company-specific weakness. That supports the bull case that ICG’s fundraising, private-credit exposure and scale can still command a higher valuation, but the bear case is that alternative asset managers remain sensitive to rates, risk appetite, private-market exits and any slowdown in client commitments.
The next scheduled catalyst is ICG’s July 15 Q1 trading statement, released on the same day as its AGM. Investors will be watching fundraising momentum, deployment, realisations and whether fee-earning AUM continues to grow after the strong FY26 base; the Exail refinancing process is an additional unscheduled catalyst to monitor through the second half of 2026.
At around 1,750p, ICG does not look expensive on headline metrics: Hargreaves Lansdown shows a market value of about £5.05 billion, a price-to-earnings ratio of 10.29 and a dividend yield near 4.97%. Price-to-earnings compares the share price with annual profit per share, while dividend yield measures annual dividend income as a percentage of the share price. On those verified figures, the stock appears attractively valued for investors comfortable with private-market cyclicality, but risky rather than defensive because its valuation still depends on fundraising conditions, credit performance, exit markets and the outcome of complex portfolio situations such as Exail.